Evidence map›Paper›PMID 30034857›Full record

ReviewJournal of thoracic disease2018

Adult veno-arterial extracorporeal life support.

Tariq Lescouflair, Ronald Figura, Anthony Tran, Ahmet Kilic

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Advanced heart failure with reduced ejection fraction.Proceedings (Baylor University. Medical Center) · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Tariq LescouflairDivision of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Ronald FiguraDivision of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Anthony TranDepartment of Surgery, University of Connecticut Health Centre, Farmington, CT, USA.
Ahmet KilicDivision of Cardiac Surgery, The Johns Hopkins Hospital, Baltimore, MD, USA.
The Ohio State University Wexner Medical Center · USJohns Hopkins Hospital · USUConn Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracorporeal life support (ECLS)/extracorporeal membrane oxygenation (ECMO) is a powerful tool in the surgeon's armamentarium. The rapid evolution of ECLS over the last four decades has improved survival in patients with cardiopulmonary failure. With the pandemic outbreak of H1N1 in 2009 and onward, the application of ECLS has only risen. Yet, amongst the outcomes reporting and improved survival, the water remains hazy in terms of outcome predictors as well as discovery of the "ideal" system. There remains much room for innovation and research related to circuit construction, ideal flow, myocardial recovery, and additional applications of ECLS. We present a review on the topic of veno-arterial extracorporeal membrane oxygenation (VA-ECMO).

Indexed as

artificial ventilationcardiopulmonary arrestExtracorporeal life support (ECLS)extracorporeal membrane oxygenation (ECMO)mechanical circulatory support

Identifiers

PMID30034857
PMCPMC6035954
OpenAlexW2789098575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.